What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Sell
36
NBY Quote, Financials, Valuation and Earnings
Last price:
$0.58
Seasonality move
:
-4.65%
Day range:
$0.57 - $0.58
52-week range:
$0.36 - $2.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.16x
P/B ratio:
0.55x
Volume:
23.4K
Avg. volume:
34.7K
1-year change:
-73.02%
Market cap:
$3.4M
Revenue:
$9.8M
EPS (TTM):
-$0.80
Earnings Data
Next earnings date for NBY
--
Most recent earnings per share
$1.42
Beat by $2.30
(Mar 31/2025)
Consensus Estimate
-$0.88
(Mar 31/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NBY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $3M | -- | -- | -$0.21 | -- |
| 03/31/2025 | Q1 | -- | -- | $1.42 | -$0.88 | $2.30 |
| 12/31/2024 | Q4 | $2.5M | $2.3M | -$0.25 | -$0.24 | -$0.01 |
| 09/30/2024 | Q3 | $2.6M | $2.4M | -$0.60 | -$0.31 | -$0.30 |
| 06/30/2024 | Q2 | $3.2M | $2.4M | -$1.37 | -$1.23 | -$0.15 |
| 03/31/2024 | Q1 | $3.3M | $2.6M | -$5.25 | -$5.25 | -- |
| 12/31/2023 | Q4 | $3.4M | $6.4M | -$28.58 | -$10.50 | -$18.08 |
| 09/30/2023 | Q3 | -- | -- | -$12.95 | -$14.18 | $1.23 |
| 06/30/2023 | Q2 | -- | -- | -$44.45 | -$19.43 | -$25.03 |
| 03/31/2023 | Q1 | -- | -- | -$29.75 | -$31.85 | $2.10 |
| 12/31/2022 | Q4 | -- | -- | -$167.30 | -$12.78 | -$154.53 |
| 09/30/2022 | Q3 | -- | -- | -$126.35 | -$36.75 | -$89.60 |
| 06/30/2022 | Q2 | -- | -- | -$50.05 | -$36.75 | -$13.30 |
| 03/31/2022 | Q1 | -- | -- | -$2.80 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$24.85 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$61.25 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$49.00 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$49.00 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$36.75 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$98.00 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$183.75 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$73.50 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$147.00 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$24.50 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$171.50 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$306.25 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$110.25 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$134.75 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$147.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$171.50 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $73.50 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$196.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$134.75 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$318.50 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$132.22 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$416.50 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$441.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1,519.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$1,396.50 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$2,168.25 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$2,254.00 | -- | -- |
NovaBay Pharmaceuticals Earnings Questions
-
How Much did NovaBay Pharmaceuticals Generate in Revenue Last Quarter?
NovaBay Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did NovaBay Pharmaceuticals Beat Earnings Last Quarter?
NovaBay Pharmaceuticals announced earnings per share of $1.42 which represents a beat of analyst forecast a -$0.88 per share.
-
Is NovaBay Pharmaceuticals Profitable?
NovaBay Pharmaceuticals reported $1.6M that represents $0.43 per share over the last quarter.
-
What is the Analyst Consensus for NovaBay Pharmaceuticals EPS Next Year?
NovaBay Pharmaceuticals's earnings are forecast to decrease from -$2.53 per share to -$3.26 per share next year representing a decrease of -66.01%.
-
When is NovaBay Pharmaceuticals's Earnings Date?
Currently, NovaBay Pharmaceuticals has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on September 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 42x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 50x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
AMBA alert for Jun 25
Ambarella [AMBA] is up 4.36% over the past day.
Buy
65
EXOD alert for Jun 25
Exodus Movement [EXOD] is down 9.63% over the past day.
Buy
78
SMR alert for Jun 25
NuScale Power [SMR] is down 10.59% over the past day.
